Eloxx Pharmaceuticals Inc (ELOX)
0.8025
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Eloxx Pharmaceuticals Free Cash Flow (Quarterly): -3.45M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -3.45M |
| June 30, 2023 | -2.066M |
| March 31, 2023 | -6.814M |
| December 31, 2022 | -5.661M |
| September 30, 2022 | -6.994M |
| June 30, 2022 | -9.754M |
| March 31, 2022 | -9.502M |
| December 31, 2021 | -9.951M |
| September 30, 2021 | -7.657M |
| June 30, 2021 | -9.797M |
| March 31, 2021 | -7.685M |
| December 31, 2020 | -4.668M |
| September 30, 2020 | -5.258M |
| June 30, 2020 | -6.316M |
| March 31, 2020 | -11.92M |
| December 31, 2019 | -9.257M |
| September 30, 2019 | -11.35M |
| June 30, 2019 | -9.624M |
| March 31, 2019 | -9.204M |
| December 31, 2018 | -9.162M |
| September 30, 2018 | -8.131M |
| June 30, 2018 | -8.555M |
| March 31, 2018 | -5.754M |
| September 30, 2017 | -0.5753M |
| June 30, 2017 | -0.5088M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.4072M |
| December 31, 2016 | -0.4379M |
| September 30, 2016 | -0.5737M |
| June 30, 2016 | -0.7148M |
| March 31, 2016 | -0.841M |
| December 31, 2015 | -0.9883M |
| September 30, 2015 | -1.132M |
| June 30, 2015 | -1.963M |
| March 31, 2015 | -1.638M |
| December 31, 2014 | -1.730M |
| September 30, 2014 | -2.274M |
| June 30, 2014 | -1.436M |
| March 31, 2014 | -1.714M |
| December 31, 2013 | -1.532M |
| September 30, 2013 | -0.8134M |
| June 30, 2013 | -1.080M |
| March 31, 2013 | -1.896M |
| December 31, 2012 | -0.6719M |
| September 30, 2012 | -0.7835M |
| June 30, 2012 | -1.215M |
| March 31, 2012 | -1.091M |
| December 31, 2011 | -1.311M |
| September 30, 2011 | -1.219M |
| June 30, 2011 | -1.273M |
| March 31, 2011 | -1.467M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-11.92M
Minimum
Mar 2020
-2.066M
Maximum
Jun 2023
-7.651M
Average
-7.671M
Median
Free Cash Flow (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.597M |
| Oragenics Inc | -1.102M |